» Articles » PMID: 35657981

Dynamic Epigenetic Age Mosaicism in the Human Atherosclerotic Artery

Overview
Journal PLoS One
Date 2022 Jun 3
PMID 35657981
Authors
Affiliations
Soon will be listed here.
Abstract

Accelerated epigenetic ageing, a promising marker of disease risk, has been detected in peripheral blood cells of atherosclerotic patients, but evidence in the vascular wall is lacking. Understanding the trends of epigenetic ageing in the atheroma may provide insights into mechanisms of atherogenesis or identify targets for molecular therapy. We surveyed DNA methylation age in two human artery samples: a set of donor-matched, paired atherosclerotic and healthy aortic portions, and a set of carotid artery atheromas. The well-characterized pan-tissue Horvath epigenetic clock was used, together with the Weidner whole-blood-specific clock as validation. For the first time, we document dynamic DNA methylation age mosaicism of the vascular wall that is atherosclerosis-related, switches from acceleration to deceleration with chronological ageing, and is consistent in human aorta and carotid atheroma. At CpG level, the Horvath epigenetic clock showed modest differential methylation between atherosclerotic and healthy aortic portions, weak association with atheroma histological grade and no clear evidence for participation in atherosclerosis-related cellular pathways. Our data suggest caution when assigning a unidirectional DNA methylation age change to the atherosclerotic arterial wall. Also, the results support previous conclusions that epigenetic ageing reflects non-disease-specific cellular alterations.

Citing Articles

DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites.

Krolevets M, Ten Cate V, Prochaska J, Schulz A, Rapp S, Tenzer S Clin Epigenetics. 2023; 15(1):56.

PMID: 36991458 PMC: 10061871. DOI: 10.1186/s13148-023-01468-y.

References
1.
Du N, Li M, Yang D . Hsa_circRNA_102541 regulates the development of atherosclerosis by targeting miR-296-5p/PLK1 pathway. Ir J Med Sci. 2021; 191(3):1153-1159. DOI: 10.1007/s11845-021-02708-x. View

2.
Jonkman T, Dekkers K, Slieker R, Grant C, Ikram M, van Greevenbroek M . Functional genomics analysis identifies T and NK cell activation as a driver of epigenetic clock progression. Genome Biol. 2022; 23(1):24. PMC: 8759260. DOI: 10.1186/s13059-021-02585-8. View

3.
Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

4.
Roetker N, Pankow J, Bressler J, Morrison A, Boerwinkle E . Prospective Study of Epigenetic Age Acceleration and Incidence of Cardiovascular Disease Outcomes in the ARIC Study (Atherosclerosis Risk in Communities). Circ Genom Precis Med. 2018; 11(3):e001937. PMC: 5863591. DOI: 10.1161/CIRCGEN.117.001937. View

5.
Schmitz L, Zhao W, Ratliff S, Goodwin J, Miao J, Lu Q . The Socioeconomic Gradient in Epigenetic Ageing Clocks: Evidence from the Multi-Ethnic Study of Atherosclerosis and the Health and Retirement Study. Epigenetics. 2021; 17(6):589-611. PMC: 9235889. DOI: 10.1080/15592294.2021.1939479. View